Metabolic syndrome: the cluster that predicts heart disease and diabetes
Metabolic syndrome is not a disease in itself but a named cluster of five cardiometabolic risk factors: a large waist, raised blood pressure, high triglycerides, low HDL cholesterol and raised fasting glucose. You are said to have it when any three of the five are present. It matters because the cluster, driven underneath by insulin resistance and visceral fat, predicts future type 2 diabetes and cardiovascular disease far better than any single number does. In a large meta-analysis it roughly doubled cardiovascular risk and raised all-cause mortality by about half.2
The five criteria, and the one rule that ties them together
Since 2009 there has been a single agreed definition, the harmonised criteria published jointly by the International Diabetes Federation, the American Heart Association and several other bodies.1 The rule is simple: meet three or more of the five thresholds below, or already be on treatment for that component, and you have metabolic syndrome. No single factor is compulsory, though waist circumference remains the most useful first screen.1
| Criterion | Threshold | What it reflects |
|---|---|---|
| Waist circumference | Population-specific. For Europid adults, 94 cm or more (men), 80 cm or more (women); lower for South Asian, Chinese and other groups (90 cm men)3 | Central and visceral fat |
| Triglycerides | 1.7 mmol/L (150 mg/dL) or higher1 | Fat handling, insulin resistance |
| HDL cholesterol | Below 1.0 mmol/L (men) or below 1.3 mmol/L (women)1 | Protective ("good") cholesterol, low when metabolism is strained |
| Blood pressure | Systolic 130 mmHg or higher, and/or diastolic 85 mmHg or higher1 | Vascular load |
| Fasting glucose | 5.6 mmol/L (100 mg/dL) or higher1 | Early glucose dysregulation |
Key facts
- Diagnosis requires three or more of five criteria; treatment for any component counts as meeting it.1
- In a meta-analysis of 87 studies and over 950,000 people, metabolic syndrome was linked to roughly a 2-fold higher cardiovascular risk and about a 1.5-fold higher all-cause mortality.2
- Even people with the syndrome but without diabetes carried clearly raised cardiovascular risk.2
- Intensive lifestyle change cut progression to type 2 diabetes by 58 percent in the US Diabetes Prevention Program, and by 71 percent in people aged 60 and over.5
- NICE advises keeping your waist to less than half your height (a waist-to-height ratio under 0.5).4
Why the cluster matters more than any single number
You could have a triglyceride level a fraction above the line, a blood pressure a few points high, and a waist a centimetre over the threshold, and on each measure a clinician might reasonably say "borderline, watch it". The insight behind metabolic syndrome is that these are not three unrelated minor faults. They tend to cluster because they share a common root, and when they appear together the combined risk is greater than the sum of three small worries.1 The cluster reframes a set of "borderline" results as a single pattern worth acting on.
That said, the label has limits, and good clinicians use it as a flag rather than a verdict. It is a binary cut-off applied to continuous risks, so it can miss someone at 2 out of 5 who is heading the wrong way, and formal cardiovascular risk tools such as QRISK already fold in several of the same inputs. Treat a positive result as a prompt to look harder, not as a diagnosis that replaces individual risk assessment.
Evidence note: The doubling of cardiovascular risk comes from Mottillo and colleagues' 2010 meta-analysis in the Journal of the American College of Cardiology, pooling 87 prospective studies. Prospective cohort data of this scale is strong for showing the cluster predicts risk, but it is observational: it shows association and prediction, not that the label itself causes anything beyond its components.2
The engine room: insulin resistance and visceral fat
Underneath all five criteria sits one largely shared mechanism: insulin resistance. When muscle, liver and fat cells respond poorly to insulin, the pancreas pumps out more of it to keep glucose normal. That excess insulin, and the fat-handling chaos behind it, nudges every component in the wrong direction at once: it raises triglycerides, lowers HDL, promotes sodium retention and higher blood pressure, and eventually lets glucose drift up.6 This is why the components travel together. They are downstream readouts of the same upstream problem. Our deeper guide to insulin resistance and its early signs covers this timeline in detail.
The most important fat is not the fat you can pinch. It is visceral fat, packed around the abdominal organs, and ectopic fat stored inside the liver and pancreas. Visceral fat is metabolically active, pouring free fatty acids and inflammatory signals into the circulation, and it tracks far more closely with metabolic risk than total body weight does.6 This is why waist circumference earns its place as the lead screen, and why the scales alone can reassure you falsely.
Who is at risk, including "TOFI"
Risk rises with age, with a family history of type 2 diabetes, with physical inactivity and poor sleep, and it is higher at lower waist thresholds in South Asian, Chinese and some other populations, which is exactly why the criteria use population-specific cut-offs.3 But the group people most often miss are those who look slim.
The shorthand is TOFI, "thin outside, fat inside", also called metabolically obese normal weight. These individuals have a normal BMI but carry excess fat internally, around and inside their organs, with relatively little under the skin. Imaging studies using MRI have shown that a meaningful minority of normal-weight adults fall into this pattern and carry the metabolic risk that goes with visceral fat, despite a reassuring number on the scales.7 The practical lesson: a normal weight does not exempt you, and a tape measure around the waist tells you more than BMI alone.
A quick self-check that needs no clinic: divide your waist measurement by your height in the same units. NICE advises keeping this below 0.5, that is, your waist under half your height. It is simple, you can do it at home, and it captures central fat better than BMI.4
The reversal levers, with honest effect sizes
The encouraging part is that metabolic syndrome is highly responsive to the same unglamorous levers, because shrinking visceral fat and restoring insulin sensitivity improves several criteria at once. Here is the evidence-led hierarchy.
1. Lose visceral and liver fat
This is the most powerful lever. In the US Diabetes Prevention Program (3,234 adults with raised glucose, New England Journal of Medicine, 2002), a programme targeting 7 percent weight loss plus 150 minutes a week of activity cut new type 2 diabetes by 58 percent over about three years, outperforming metformin.5 In the UK DiRECT trial (Lean, Leslie, Taylor and colleagues, The Lancet, 2018), a structured low-calorie programme delivered in routine GP practices achieved type 2 diabetes remission in 46 percent of participants at one year, against 4 percent in usual care, with remission strongly tied to the amount of weight lost.8 The honest caveat is durability: maintaining the loss is the hard part.
2. Exercise, including resistance training
Movement works through two routes. Acutely, contracting muscle pulls glucose in independently of insulin, so a single session improves insulin action for the next day or two. Chronically, building muscle expands the tissue that disposes of glucose. Aerobic and resistance training both help; resistance training deserves specific mention because muscle is the main site of glucose disposal. A meta-analysis of randomised trials in people with type 2 diabetes found resistance training improved markers of insulin resistance and produced small but real reductions in HbA1c, on the order of 0.3 percentage points.9 The practical reading: combine resistance work with regular moderate cardio, most days.
3. Diet quality
For the cluster specifically, dietary pattern matters as much as any single nutrient. In the Spanish PREDIMED randomised trial, among participants who already had metabolic syndrome, a Mediterranean diet enriched with extra-virgin olive oil or nuts made reversal of the syndrome more likely than a low-fat control diet (hazard ratio around 1.3), largely through smaller waists and better glucose.10 Beyond any named diet, the strongest lever is whatever sustainably reduces ectopic fat, which usually means an overall energy deficit you can actually keep to.
4. Protect your sleep
Sleep is an underrated metabolic lever. A meta-analysis of nine prospective cohorts (over 235,000 people) found short sleep was associated with a modestly higher risk of metabolic syndrome (about 15 percent), and controlled laboratory studies show even a few nights of short sleep can blunt insulin sensitivity.11 The effect sizes are modest, so do not over-read them, but the direction is consistent: chronically short sleep nudges the whole cluster the wrong way.
Safety: Trials like DiRECT used medically supervised, very-low-calorie phases. If you take insulin, a sulfonylurea or blood-pressure medication, do not begin aggressive calorie restriction, fasting or a sudden high-volume exercise programme without medical review, because doses often need lowering to avoid dangerously low blood sugar or blood pressure. None of this is medical advice.
UK context: what to check and where to turn
In the UK there is no single "metabolic syndrome" test you can book, but every component is routinely measured. An NHS Health Check (offered to adults aged 40 to 74 in England) covers blood pressure, cholesterol and diabetes risk in one go. If your HbA1c lands in the non-diabetic hyperglycaemia range, 42 to 47 mmol/mol, your GP can refer you to the free Healthier You: NHS Diabetes Prevention Programme, a nine-month, evidence-based lifestyle course shown to cut progression to type 2 diabetes.12 If you prefer to map your own numbers to actions first, our stack builder can help you organise the picture.
What to ask your GP
What to ask your GP
- Can we review all five components together, my waist, blood pressure, a fasting lipid panel (triglycerides and HDL) and fasting glucose or HbA1c, rather than one at a time?
- Given my ethnicity, which waist threshold applies to me?3
- Am I in the non-diabetic hyperglycaemia range (HbA1c 42 to 47 mmol/mol), and if so, can you refer me to the NHS Diabetes Prevention Programme?12
- What is my formal cardiovascular risk (for example my QRISK score), and does it change how we manage my blood pressure or cholesterol?
- If I start losing weight quickly, do any of my current medications need adjusting?
What to do next
References
- Alberti KGMM, Eckel RH, Grundy SM, et al., 2009. Harmonizing the metabolic syndrome: a joint interim statement (IDF, NHLBI, AHA, WHF, IAS, IASO). Circulation. link
- Mottillo S, Filion KB, Genest J, et al., 2010. The metabolic syndrome and cardiovascular risk: a systematic review and meta-analysis. Journal of the American College of Cardiology. link
- Alberti KGMM, Zimmet P, Shaw J, 2006. Metabolic syndrome: a new worldwide definition. A consensus statement from the International Diabetes Federation. Diabetic Medicine. link
- NICE, 2022. Keep the size of your waist to less than half of your height (guideline NG246, overweight and obesity management). link
- Knowler WC, Barrett-Connor E, Fowler SE, et al. (Diabetes Prevention Program Research Group), 2002. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine. link
- Swarup S, Ahmed I, Grigorova Y, Zeltser R, 2024. Metabolic Syndrome. StatPearls. link
- Thomas EL, Frost G, Taylor-Robinson SD, Bell JD, 2012. Excess body fat in obese and normal-weight subjects (TOFI). Nutrition Research Reviews. link
- Lean MEJ, Leslie WS, Barnes AC, et al., 2018. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. The Lancet. link
- Jansson AK, Chan LX, Lubans DR, et al., 2022. Effect of resistance training on glycaemic control and insulin resistance in type 2 diabetes: a systematic review and meta-analysis. BMJ Open Diabetes Research and Care. link
- Babio N, Toledo E, Estruch R, et al. (PREDIMED), 2014. Mediterranean diets and metabolic syndrome status in the PREDIMED randomized trial. Canadian Medical Association Journal (CMAJ). link
- Che T, Yan C, Tian D, et al., 2021. Sleep duration and the risk of metabolic syndrome in adults: a systematic review and meta-analysis. Frontiers in Neurology. link
- NHS England / Public Health England. Healthier You: NHS Diabetes Prevention Programme, non-diabetic hyperglycaemia. link
This article is educational and does not constitute medical advice, diagnosis, or a treatment recommendation. Medication uses described as “off-label” are not licensed for that purpose in the UK and should only be considered under qualified clinical supervision. Always speak to your GP, pharmacist, or a registered specialist before starting, stopping, or changing any treatment. If you have severe or alarm symptoms - unintentional weight loss, blood in your stool, difficulty swallowing, persistent vomiting, a fever, or severe pain - seek urgent medical care.